Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / G•••••••• C•••••• L••

G•••••••• C•••••• L••

Institutional venture firmLarkspur, CAg•••••••••.comSEC venture capital fund adviser

Our Mission We invest in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. Our focus is on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device,

venture manager, reported GAV $63M across 1 vehicles

Importance
11
low
Active deployment
0
low
Emerging
0
low
Completeness
63
high
Freshness
98
high
Research priority
2
low
Identity and regulatory footprint
Headquarters
Larkspur, CAadviserinfo.sec.gov
Office address
60 E. SIR FRANCIS DRAKE BLVD., SUITE 208, Larkspur, CA, 94939adviserinfo.sec.gov
Business phone
415-937-5414adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Jan 28, 2026
Private funds reported
1 (1 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$61.0Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business phone
415-937-5414adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
healthcare, medtech
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
G•••••••• C•••••• F••• I• L•••FundunknownUnknown$62.5M
Mar 25, 2024
93$0Oct 22, 2021
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
2 current, 0 departed
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
2 dated events
  1. Nov 5, 2021
    G•••••••• C•••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)
  2. Nov 5, 2021
    G•••••••• C•••••• F••• I• L••• first reported on Form ADV by G•••••••• C•••••• L•• (Venture Capital Fund)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $63M across 1 vehicles
Evidence
42 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2021-11-05Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-01-28Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-25Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2021-11-05Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone415-937-5414Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone415-937-5414Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionOur Mission We invest in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. Our focus is on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device,
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionOur Mission We invest in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. Our focus is on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device,
meta description
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersLarkspur, CAJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersLarkspur, CAMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address60 E. SIR FRANCIS DRAKE BLVD., SUITE 208, Larkspur, CA, 94939Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address60 E. SIR FRANCIS DRAKE BLVD., SUITE 208, Larkspur, CA, 94939Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://g•••••••••.com/
0 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://g•••••••••.com/
0 entries read
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported1Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported1Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$61.0MJan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$62.5MMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorshealthcare,medtech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,medtech
sector words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://g•••••••••.com/
1 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://g•••••••••.com/
1 name/title pairs read
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported1Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported1Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://g•••••••••.com/Jan 28, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Websitehttps://g•••••••••.com/Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleHome - G•••••••• Capital
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleHome - G•••••••• Capital
title tag
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)